Endocrinologia e Metabologia

Contraceptive Selection for the Endocrine Patient: What an Endocrinologist Should Know.

Endocrine reviews. 2025 Jun; doi: 10.1210/endrev/bnaf016. pii: bnaf016.

Incretins and the cardiovascular system: bridging digestion with metabolism.

The lancet. Diabetes & endocrinology. 2025 Jul; doi: 10.1016/S2213-8587(25)00166-4. pii: S2213-8587(25)00166-4.

Selpercatinib in the treatment of thyroid cancer.

Future oncology (London, England). 2025 Jul; 1-8. doi: 10.1080/14796694.2025.2531575. pii: .

Managing noninsulin glucose-lowering medications before surgery: A comparison of clinical practice guidelines.

Cleveland Clinic journal of medicine. 2025 Jul; 92(Jul):429-437. doi: 10.3949/ccjm.92a.24118. pii: .

Undetectable Serum Thyroglobulin in Patients With Differentiated Thyroid Cancer: Antithyroglobulin Antibodies, Assay Limitation, or Other?

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists. 2025 Jun; doi: 10.1016/j.eprac.2025.06.001. pii: S1530-891X(25)00914-0.

Comparison of Semaglutide or Dulaglutide Versus Empagliflozin for Risk for Death and Cardiovascular Outcomes Among Patients With Type 2 Diabetes : Two Target Trial Emulation Studies.

Annals of internal medicine. 2025 Jun; doi: 10.7326/ANNALS-24-00775. pii: .

Tirzepatide as Compared with Semaglutide for the Treatment of Obesity.

The New England journal of medicine. 2025 Jul; 393(Jul):26-36. doi: 10.1056/NEJMoa2416394. pii: .

[Management of follicular cell-derived thyroid cancer in 2025].

Revue medicale suisse. 2025 Jun; 21(Jun):1210-1215. doi: 10.53738/REVMED.2025.21.922.47328. pii: .

Tirzepatide and cardiometabolic parameters in obesity: Summary of current evidence.

Diabetes, obesity & metabolism. 2025 Jun; doi: 10.1111/dom.16549. pii: .

Pharmacologic options for the treatment of overweight and obesity.

Menopause (New York, N.Y.). 2025 Jun; doi: 10.1097/GME.0000000000002573. pii: .

Tirzepatide for Obesity Treatment and Diabetes Prevention.

The New England journal of medicine. 2025 Jun; 392(Jun):2491-2492. doi: 10.1056/NEJMc2504728. pii: 10.1056/NEJMc2504728#sa1.

Approach to the Patient With Cyclical Cushing Syndrome.

The Journal of clinical endocrinology and metabolism. 2025 Jun; 110(Jun):e2338-e2346. doi: 10.1210/clinem/dgae864. pii: .

Approach to Lipid Management in the Patient With Diabetes.

The Journal of clinical endocrinology and metabolism. 2025 May; 110(May):1740-1755. doi: 10.1210/clinem/dgaf018. pii: .

Diabetes Deprescribing in Older Adults: A Randomized Clinical Trial.

JAMA internal medicine. 2025 Jun; doi: 10.1001/jamainternmed.2025.2015. pii: e252015.

Hypoparathyroidism: diagnosis, management and emerging therapies.

Nature reviews. Endocrinology. 2025 Jun; 21(Jun):360-374. doi: 10.1038/s41574-024-01075-8. pii: .

Genetic origin of multifocal sporadic medullary thyroid cancer and C-cell hyperplasia.

European journal of endocrinology. 2025 May; 192(May):737-743. doi: 10.1093/ejendo/lvaf109. pii: .

Less is more: once vs. multiple radioactive iodine (RAI) therapy in patients with RAI-avid pulmonary micrometastatic differentiated thyroid cancer.

European journal of nuclear medicine and molecular imaging. 2025 May; doi: 10.1007/s00259-025-07339-3. pii: .

The diagnostic challenges of medullary thyroid carcinoma: A practical guide for cytopathologists.

Cancer cytopathology. 2025 Jun; 133(Jun):e70023. doi: 10.1002/cncy.70023. pii: e70023.

The utility of 68Ga-DOTATATE and 18F-FDG PET/CT in predicting the response to tyrosine kinase inhibitors in patients with advanced medullary thyroid cancer.

Thyroid research. 2025 Jun; 18(Jun):31. doi: 10.1186/s13044-025-00250-x. pii: 31.

Adjuvant External Beam Radiotherapy Reduces Local Recurrence in Poorly Differentiated Thyroid Cancer : A Multicenter Retrospective Cohort Study Describing Outcomes in the Treatment of Resectable Poorly Differentiated Thyroid Cancer.

Annals of surgical oncology. 2025 May; doi: 10.1245/s10434-025-17434-2. pii: .

ASO Visual Abstract: Adjuvant External Beam Radiotherapy Reduces Local Recurrence in Poorly Differentiated Thyroid Cancer : A Multicenter Retrospective Cohort Study Describing Outcomes in the Treatment of Resectable Poorly Differentiated Thyroid Cancer.

Annals of surgical oncology. 2025 Jun; doi: 10.1245/s10434-025-17583-4. pii: .

New obesity definition sidelines BMI to focus on health.

Nature. 2025 Jan; 637(Jan):773-774. doi: 10.1038/d41586-025-00123-1. pii: .

Definition and diagnostic criteria of clinical obesity.

The lancet. Diabetes & endocrinology. 2025 Mar; 13(Mar):221-262. doi: 10.1016/S2213-8587(24)00316-4. pii: S2213-8587(24)00316-4.

The Venice Declaration: Obesity as a Disease-A Call to Action for Diagnosis, Multimodal Treatment, and Policy Change.

Obesity surgery. 2025 Apr; doi: 10.1007/s11695-025-07869-7. pii: .

Basal and Stimulated Inhibin B in Pubertal Disorders.

The Journal of clinical endocrinology and metabolism. 2025 Jun; 110(Jun):e2136-e2145. doi: 10.1210/clinem/dgaf005. pii: .

Managing obesity in children: a clinical practice guideline.

CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne. 2025 Apr; 197(Apr):E372-E389. doi: 10.1503/cmaj.241456. pii: .

9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes-2025.

Diabetes care. 2025 Jan; 48(Jan):S181-S206. doi: 10.2337/dc25-S009. pii: .

American Association of Clinical Endocrinology Clinical Practice Guideline on Pharmacologic Management of Adults With Dyslipidemia.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists. 2025 Feb; 31(Feb):236-262. doi: 10.1016/j.eprac.2024.09.016. pii: S1530-891X(24)00691-8.

Hyperglycemic crises in adults: A look at the 2024 consensus report.

Cleveland Clinic journal of medicine. 2025 Mar; 92(Mar):152-158. doi: 10.3949/ccjm.92a.24089. pii: .

Highlights of the 2025 American Association of Clinical Endocrinology Clinical Practice Guideline on Pharmacologic Management of Adults With Dyslipidemia.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists. 2024 Dec; doi: 10.1016/j.eprac.2024.11.006. pii: S1530-891X(24)00831-0.

Screening for Osteoporosis to Prevent Fractures: US Preventive Services Task Force Recommendation Statement.

JAMA. 2025 Feb; 333(Feb):498-508. doi: 10.1001/jama.2024.27154. pii: .

Compounded GLP-1 and Dual GIP/GLP-1 Receptor Agonists: A Statement from the American Diabetes Association.

Diabetes care. 2025 Feb; 48(Feb):177-181. doi: 10.2337/dci24-0091. pii: .

Evaluation of the evidence-based practices for the management of PCOS in the Latin America context: the consensus of the Latin American Association of Gynecological Endocrinology (ALEG).

Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology. 2025 Dec; 41(Dec):2456578. doi: 10.1080/09513590.2025.2456578. pii: .

2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes-2025.

Diabetes care. 2025 Jan; 48(Jan):S27-S49. doi: 10.2337/dc25-S002. pii: .

4. Comprehensive Medical Evaluation and Assessment of Comorbidities: Standards of Care in Diabetes-2025.

Diabetes care. 2025 Jan; 48(Jan):S59-S85. doi: 10.2337/dc25-S004. pii: .

6. Glycemic Goals and Hypoglycemia: Standards of Care in Diabetes-2025.

Diabetes care. 2025 Jan; 48(Jan):S128-S145. doi: 10.2337/dc25-S006. pii: .

7. Diabetes Technology: Standards of Care in Diabetes-2025.

Diabetes care. 2025 Jan; 48(Jan):S146-S166. doi: 10.2337/dc25-S007. pii: .

13. Older Adults: Standards of Care in Diabetes-2025.

Diabetes care. 2025 Jan; 48(Jan):S266-S282. doi: 10.2337/dc25-S013. pii: .

Exogenous Opioids and the Human Endocrine System: An Endocrine Society Scientific Statement.

Endocrine reviews. 2024 Nov; 45(Nov):773-794. doi: 10.1210/endrev/bnae023. pii: .

Consensus statement on the management of incidentally discovered FDG avid thyroid nodules in patients being investigated for other cancers.

Clinical endocrinology. 2024 Nov; 101(Nov):557-561. doi: 10.1111/cen.14905. pii: .

Clinician's Guide for Pediatric Anti-obesity Medications.

Pediatric clinics of North America. 2024 Oct; 71(Oct):957-980. doi: 10.1016/j.pcl.2024.07.006. pii: S0031-3955(24)00102-0.

European Society of Endocrinology and Endocrine Society Joint Clinical Guideline: Diagnosis and therapy of glucocorticoid-induced adrenal insufficiency.

European journal of endocrinology. 2024 May; 190(May):G25-G51. doi: 10.1093/ejendo/lvae029. pii: .

Consensus Statement on Vitamin D Status Assessment and Supplementation: Whys, Whens, and Hows.

Endocrine reviews. 2024 Sep; 45(Sep):625-654. doi: 10.1210/endrev/bnae009. pii: .

DCRM 2.0: Multispecialty practice recommendations for the management of diabetes, cardiorenal, and metabolic diseases.

Metabolism: clinical and experimental. 2024 Oct; 159(Oct):155931. doi: 10.1016/j.metabol.2024.155931. pii: S0026-0495(24)00158-6.

Diabetic myocardial disorder. A clinical consensus statement of the Heart Failure Association of the ESC and the ESC Working Group on Myocardial & Pericardial Diseases.

European journal of heart failure. 2024 Jun; doi: 10.1002/ejhf.3347. pii: .

EMAS position statement: Thyroid disease and menopause.

Maturitas. 2024 Jul; 185(Jul):107991. doi: 10.1016/j.maturitas.2024.107991. pii: S0378-5122(24)00086-0.

International Guidelines for the Diagnosis and Management of Hyperinsulinism.

Hormone research in paediatrics. 2024 ; 97():279-298. doi: 10.1159/000531766. pii: .

[A consensus report by the Working Group on Eating Disorders of Sociedad Española de Nutrición Clínica y Metabolismo (GTTCA-SENPE). Evaluation, medical and nutritional management of anorexia nervosa. Update 2023].

Nutricion hospitalaria. 2024 Mar; 41(Mar):1-60. doi: 10.20960/nh.05175. pii: .

Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus.

Diabetes care. 2023 Oct; 46(Oct):e151-e199. doi: 10.2337/dci23-0036. pii: .

Diagnosis and management of prolactin-secreting pituitary adenomas: a Pituitary Society international Consensus Statement.

Nature reviews. Endocrinology. 2023 Dec; 19(Dec):722-740. doi: 10.1038/s41574-023-00886-5. pii: .

New Horizons in Klinefelter Syndrome: Current Evidence, Gaps, and Research Priorities.

Endocrine reviews. 2025 Jul; 46(Jul):447-478. doi: 10.1210/endrev/bnaf005. pii: .

Selpercatinib in the treatment of thyroid cancer.

Future oncology (London, England). 2025 Jul; 1-8. doi: 10.1080/14796694.2025.2531575. pii: .

Incretins and the cardiovascular system: bridging digestion with metabolism.

The lancet. Diabetes & endocrinology. 2025 Jul; doi: 10.1016/S2213-8587(25)00166-4. pii: S2213-8587(25)00166-4.

Tirzepatide as Compared with Semaglutide for the Treatment of Obesity.

The New England journal of medicine. 2025 Jul; 393(Jul):26-36. doi: 10.1056/NEJMoa2416394. pii: .

Managing noninsulin glucose-lowering medications before surgery: A comparison of clinical practice guidelines.

Cleveland Clinic journal of medicine. 2025 Jul; 92(Jul):429-437. doi: 10.3949/ccjm.92a.24118. pii: .

Encouraging the prescribing of SGLT2i and GLP-1RA medications to reduce cardiovascular and renal risk in patients with type 2 diabetes: Rationale and design of a randomized controlled trial.

American heart journal. 2025 Jul; 285(Jul):39-51. doi: 10.1016/j.ahj.2025.02.007. pii: S0002-8703(25)00038-9.

Tirzepatide for Obesity Treatment and Diabetes Prevention.

The New England journal of medicine. 2025 Jun; 392(Jun):2491-2492. doi: 10.1056/NEJMc2504728. pii: 10.1056/NEJMc2504728#sa1.

Tirzepatide and cardiometabolic parameters in obesity: Summary of current evidence.

Diabetes, obesity & metabolism. 2025 Jun; doi: 10.1111/dom.16549. pii: .

Pharmacologic options for the treatment of overweight and obesity.

Menopause (New York, N.Y.). 2025 Jun; doi: 10.1097/GME.0000000000002573. pii: .

Diabetes Deprescribing in Older Adults: A Randomized Clinical Trial.

JAMA internal medicine. 2025 Jun; doi: 10.1001/jamainternmed.2025.2015. pii: e252015.